Penserra Capital Management LLC Axsome Therapeutics, Inc. Transaction History
Penserra Capital Management LLC
- $5.61 Billion
- Q1 2025
A detailed history of Penserra Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 19,112 shares of AXSM stock, worth $2.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,112Holding current value
$2.1 Million% of portfolio
0.04%Shares
7 transactions
Others Institutions Holding AXSM
# of Institutions
358Shares Held
36.4MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$445 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$363 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$161 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$153 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...